Kommisjonens gjennomføringsforordning (EU) 2026/1016 av 7. mai 2026 om fornyelse av godkjenningen av et preparat av endo-1,4-beta-xylanase og endo-1,3(4)-beta-glukanase framstilt av Talaromyces versatilis IMI 378536 og Talaromyces versatilis DSM 26702 som tilsetningsstoff i fôr til kyllinger til oppfôring og egglegging, verpehøner, kalkuner til oppfôring og avlsdyr, og mindre fjørfearter til oppfôring og egglegging, godkjenning av et preparat av endo-1,4-beta-xylanase og endo-1,3(4)-beta-glukanase framstilt av Talaromyces versatilis IMI 378536 og Talaromyces versatilis DSM 26702 som tilsetningsstoff i fôr til kyllinger til avl, avlskyllinger, kalkuner til avl, mindre fjørfearter til avl, og mindre fjørfearter til egglegging og avl (innehaver av godkjenning: Adisseo France S.A.S.), og om oppheving av gjennomføringsforordning (EU) 2015/661, (EU) 2015/2304 og (EU) 2017/210
Fornyet godkjenning av et preparet av endo-1,4-betaxylanase og endo-1,3(4)-betaglukanase som tilsetningsstoff i fôr
Kommisjonsforordning publisert i EU-tidende
Bakgrunn
(fra kommisjonsforordningen)
(1) Regulation (EC) No 1831/2003 provides for the authorisation of additives for use in animal nutrition and for the grounds and procedures for granting and renewing such an authorisation.
(2) A preparation of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with Talaromyces versatilis IMI 378536 and Talaromyces versatilis DSM 26702 was authorised for a period of 10 years as a feed additive for chickens for fattening, chickens reared for laying and minor poultry species for fattening and reared for laying by Commission Implementing Regulation (EU) 2015/661 (2), for turkeys for fattening and for breeding by Commission Implementing Regulation (EU) 2015/2304 (3) and for laying hens by Commission Implementing Regulation (EU) 2017/210 (4).
(3) In accordance with Article 14(1) of Regulation (EC) No 1831/2003, an application was submitted for the renewal of the authorisation of the preparation of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with Talaromyces versatilis IMI 378536 and Talaromyces versatilis DSM 26702 as a feed additive for chickens for fattening and reared for laying, laying hens, turkeys for fattening and reared for breeding, and minor poultry species for fattening and reared for laying, requesting that additive to be classified in the additive category ‘zootechnical additives’ and in the functional group ‘digestibility enhancers’. In accordance with Article 7 of Regulation (EC) No 1831/2003, that application also concerned the authorisation of a new use of the same preparation as a feed additive for chickens reared for breeding, chickens for breeding, turkeys for breeding, minor poultry species reared for breeding, and minor poultry species for laying and breeding, requesting that additive to be classified in the additive category ‘zootechnical additives’ and in the functional group ‘digestibility enhancers’. That application was accompanied by the particulars and documents required under Article 14(2) and Article 7(3) of Regulation (EC) No 1831/2003.
(4) The European Food Safety Authority (‘the Authority’) concluded in its opinion of 25 June 2025 (5) that, under the current authorised conditions of use and considering the fact that the manufacturing and composition of the additive have not been substantially modified, the preparation of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with Talaromyces versatilis IMI 378536 and Talaromyces versatilis DSM 26702 remains safe for the target species, consumers and the environment. In addition, the Authority concluded that, regarding the extension of use to all poultry species, the additive is safe for the target species, consumers, and the environment. It further concluded that the preparation is not an irritant to the skin or eyes, but should be considered a potential skin and respiratory sensitiser and any exposure by inhalation is considered a risk. The Authority stated that the application for renewal of the authorisation does not include a proposal for amending or supplementing the conditions of the original authorisation that would have an impact on the efficacy of the additive. Therefore, it concluded that there is no need for assessing the efficacy of the additive in the context of the renewal of the authorisation. It also considered that the conclusions reached in the original authorisation can be extended to other species and therefore concluded that the additive has the potential to be efficacious in all poultry species at a minimum inclusion level of 1100 VU endo-1,4-beta-xylanase and 760 VU endo-1,3(4)-beta-glucanase/kg complete feed. The Authority did not consider that there is a need for specific requirements of post-market monitoring.
(5) The Reference Laboratory set up by Regulation (EC) No 1831/2003 considered that the conclusions and recommendations reached in a previous assessment concerning another application for the authorisation of the same additive and verified by the Authority in its opinion of 2 July 2014 (6) are valid and applicable for the current application. In accordance with Article 5(4), points (a) and (c), of Commission Regulation (EC) No 378/2005 (7), an evaluation report of the Reference Laboratory is therefore not required.
(6) In view of the above, the Commission considers that the preparation of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with Talaromyces versatilis IMI 378536 and Talaromyces versatilis DSM 26702 satisfies the conditions provided for in Article 5 of Regulation (EC) No 1831/2003. Accordingly, the authorisation of that additive should be renewed for chickens for fattening and reared for laying, laying hens, turkeys for fattening and reared for breeding, and minor poultry species for fattening and reared for laying. Furthermore, the use of that preparation should be authorised for chickens reared for breeding, chickens for breeding, turkeys for breeding, minor poultry species reared for breeding, and minor poultry species for laying and breeding. In addition, the Commission considers that appropriate protective measures should be taken to prevent adverse effects on the health of the users of the additive. Those protective measures should be without prejudice to other workers’ safety requirements under Union law.
(7) As a consequence of the renewal of the authorisation of the preparation of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with Talaromyces versatilis IMI 378536 and Talaromyces versatilis DSM 26702 as a feed additive for chickens for fattening and reared for laying, laying hens, turkeys for fattening and reared for breeding, and minor poultry species for fattening and reared for laying, Implementing Regulations (EU) 2015/661, (EU) 2015/2304 and (EU) 2017/210 should be repealed.
(8) Since safety reasons do not require the immediate application of the modifications to the conditions of authorisation of the preparation of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced with Talaromyces versatilis IMI 378536 and Talaromyces versatilis DSM 26702 for chickens for fattening and reared for laying, laying hens, turkeys for fattening and reared for breeding, and minor poultry species for fattening and reared for laying, it is appropriate to provide for a transitional period for interested parties to prepare themselves to meet the new requirements resulting from the renewal of the authorisation.
(9) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,